EndoSuture与开窗式主动脉瘤修复术治疗近端瘤颈不良的腹主动脉瘤的比较
单中心回顾性研究纳入391例近端瘤颈不良的腹主动脉瘤患者,经倾向评分加权后比较EndoSuture动脉瘤修复(ESAR)与开窗式血管腔内主动脉修复(FEVAR)。FEVAR与更少的IA型内漏和更大的瘤囊回缩相关,但1年及3年再干预更多,3年生存率有改善趋势但无统计学显著性,新发慢性透析无显著差异。
要点
- FEVAR较ESAR与更少IA型内漏(HR 0.341)和更大瘤囊回缩(HR 3.92)相关。
- FEVAR较ESAR与更多1年动脉瘤相关再干预(OR 4.33)相关,多为分支相关。
- 3年免于再干预率FEVAR低于ESAR,新发慢性透析无显著差异。
核心结论
- 在倾向匹配队列中,治疗近端瘤颈不良的腹主动脉瘤时,FEVAR较ESAR与更少IA型内漏和更大瘤囊回缩相关,对长期肾功能无不利影响。
- FEVAR组再干预更多,多为分支相关。
- 作者等待当前比较这些策略的随机前瞻性试验结果,以进一步确定这些临床差异对动脉瘤相关死亡率的影响。
研究设计与样本
- 单中心回顾性研究,回顾2012年至2024年因近端瘤颈不良的腹主动脉瘤行择期ESAR或FEVAR的患者。
- 排除标准包括肾旁或胸腹主动脉瘤、超说明书修改和非标准FEVAR配置。
- 基于年龄、手术年份、术前估算肾小球滤过率、瘤颈长度、瘤颈直径和肾下成角生成倾向匹配权重。
- 391例患者中纳入60例ESAR和207例FEVAR;倾向评分调整回归分析纳入58例ESAR和169例FEVAR。
主要发现
- FEVAR患者较ESAR患者更年轻(74.4岁 vs 79.8岁;P < .001),瘤颈直径更大(25.0 mm vs 23.6 mm;P = .016),瘤颈长度更短(5.0 mm vs 9.8 mm;P < .001),肾下成角更小(20° vs 40°;P < .001)。
- 倾向评分调整回归中,FEVAR较ESAR与更少IA型内漏相关(HR 0.341;95%CI 0.061-0.72;P = .031),与更大瘤囊回缩相关(HR 3.92;95%CI 1.25-5.14;P = .02)。
- FEVAR较ESAR与更多1年动脉瘤相关再干预相关(OR 4.33;95%CI 1.12-10.54;P = .046)。
- Kaplan-Meier分析中,FEVAR较ESAR与3年免于再干预率降低相关(71.8%[95%CI 0.63-0.78] vs 93.5%[95%CI 0.80-0.97];log-rank P = .019),3年生存率有改善趋势(79.15%[95%CI 0.70-0.85] vs 61.5%[95%CI 0.44-0.74];log-rank P = .095)。
- 3年新发慢性透析在ESAR与FEVAR之间无显著差异(94.2%[95%CI 0.82-0.98] vs 97.4%[95%CI 0.93-0.99];log-rank P = .124)。
临床怎么用
- 作者等待当前比较这些策略的随机前瞻性试验结果,以进一步确定这些临床差异对动脉瘤相关死亡率的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hostile aortic neck anatomy is associated with loss of proximal seal and increased late reinterventions. Although both EndoSuture aneurysm repair (ESAR) and fenestrated endovascular aortic repair (FEVAR) are commercially available options for treatment of short neck aneurysms, branch vessel patency is a potential tradeoff for improved seal with FEVAR owing to the incorporation of renovisceral vessels. This study compares the performance of ESAR vs FEVAR in hostile aortic necks. METHODS: Patients who underwent elective ESAR or FEVAR for hostile neck AAAs at a single center from 2012 to 2024 were reviewed retrospectively. Exclusion criteria included pararenal or thoracoabdominal aortic aneurysm, off-label modifications, and nonstandard FEVAR configurations. Propensity matching weights were generated based on age, year of operation, preoperative estimated glomerular filtration rate, neck length, neck diameter, and infrarenal angulation. Rates of survival, reintervention, dialysis, chronic kidney disease stage progression, type IA endoleak (EL), and sac regression (>5 mm) were assessed at latest follow-up. RESULTS: Of 391 patients, 60 with ESAR and 207 with FEVAR were included. FEVAR patients were younger (74.4 years vs 79.8 years; P < .001) with larger neck diameters (25.0 mm vs 23.6 mm; P = .016), shorter neck length (5.0 mm vs 9.8 mm; P < .001), and decreased infrarenal angulation (20° vs 40°; P < .001). After propensity score-adjusted regression (58 ESAR, 169 FEVAR), FEVAR, compared with ESAR, was associated with decreased IA EL (hazard ratio, 0.341; 95% confidence interval [CI], 0.061-0.72; P = .031) and increased sac regression (hazard ratio, 3.92; 95% CI, 1.25-5.14; P = .02). Notably, FEVAR was associated with increased 1-year aneurysm-related reintervention (odds ratio, 4.33; 95% CI, 1.12-10.54; P = .046). On Kaplan-Meier analysis, FEVAR was associated with reduced freedom from reinterventions at 3 years (71.8% [95% CI, 0.63-0.78] vs 93.5% [95% CI, 0.80-0.97]; log-rank P = .019) but a trend toward improved survival at 3 years (79.15% [95% CI, 0.70-0.85] vs 61.5% [95% CI, 0.44-0.74]; log-rank P = .095). There was no significant difference in new-onset chronic dialysis between ESAR and FEVAR at 3 years (94.2% [95% CI, 0.82-0.98] vs 97.4% [95% CI, 0.93-0.99]; log-rank P = .124). CONCLUSIONS: In the treatment of abdominal aortic aneurysms with hostile neck anatomy in this propensity-matched cohort, FEVAR was associated with fewer type IA ELs and greater sac regression compared with ESAR, with no detrimental impact on long-term renal function. There were more reinterventions, mostly branch related, in the FEVAR group. We await the results of the current randomized prospective trial comparing these strategies to further determine the impact of these clinical differences on aneurysm-related mortality.
引用
- Fereydooni A, Satam K, Dossabhoy S, et al. Comparison of EndoSuture vs fenestrated aortic aneurysm repair in treatment of abdominal aortic aneurysms with unfavorable neck anatomy. J Vasc Surg. 2024. PMID: 39603282. doi:10.1016/j.jvs.2024.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。